ZYNE Chart
- 52-Week Range: $0.86 - $5.98
- Market Capitalization: $41.93M
- Short Percentage: 0%
- Target Price: $6.60
- Shares Outstanding: 43.62M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
ZYNE released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Zynerba ends 1Q with strong $69.7M cash runway to advance its novel Zygel CBD Gel for Fragile X SyndromeProactive Investors | May 16th
- Zynerba Pharmaceuticals to Present at the Needham Virtual Healthcare ConferenceGlobeNewsWire | April 5th
- Zynerba Pharmaceuticals to Participate in the Cantor Rare Orphan Disease SummitGlobeNewsWire | March 22nd
- Canaccord Genuity calls Zynerba "undervalued," reiterates Buy rating after positive 4Q resultsProactive Investors | March 2nd
- Zynerba ends 4Q flush with $67.8M cash runway to advance its flagship Zygel CBD Gel for Fragile X SyndromeProactive Investors | March 1st
Company Info
Website: https://www.zynerba.com
Address: 80 West Lancaster Avenue, Devon, PA, United States, 19333
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full time employees: 28
Address: 80 West Lancaster Avenue, Devon, PA, United States, 19333
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full time employees: 28
$ZYNE rocket fuel tanks are full. Gonna shoot to the stars
$ZYNE ADDING MORE…
$ZYNE How can this stock move so little? Damn
$ZYNE hold
$ZYNE added
$ZYNE Mindset is key
$ZYNE just waiting ….
$ZYNE the bulls in here
$ZYNE who else excited??
$ZYNE I blocked some bears and I liked it!